Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS).

ABSTRACT:

Importance

Retrospective case series have identified having cancer and receiving treatment for cancer as risk factors for inferior COVID-19 outcomes.

Objective

To determine risk factors for hospitalization and death in patients with cancer with COVID-19 infection.

Design, setting, and participants

The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS) is a prospective longitudinal natural history cohort study examining the impact of COVID-19 on patients with cancer. Adults were eligible within 14 days of an initial positive SARS-CoV-2 test result if they were receiving active treatment for cancer or had prior stem cell/bone marrow transplant or CAR T-cell treatment. The statistical analysis took place between September 2024 and April 2025.

Main ou

SUBMITTER: Rini BI 

PROVIDER: S-EPMC12272355 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature